AIM ImmunoTech Inc (AIM)
0.2101
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.21
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Cash from Operations (Quarterly): -3.11M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.11M |
| June 30, 2024 | -3.008M |
| March 31, 2024 | -4.815M |
| December 31, 2023 | -9.758M |
| September 30, 2023 | -5.671M |
| June 30, 2023 | -2.158M |
| March 31, 2023 | -3.68M |
| December 31, 2022 | -6.069M |
| September 30, 2022 | -4.968M |
| June 30, 2022 | -2.313M |
| March 31, 2022 | -2.758M |
| December 31, 2021 | -5.745M |
| September 30, 2021 | -3.457M |
| June 30, 2021 | -1.718M |
| March 31, 2021 | -3.045M |
| December 31, 2020 | -2.854M |
| September 30, 2020 | -2.989M |
| June 30, 2020 | -1.275M |
| March 31, 2020 | -3.25M |
| December 31, 2019 | -2.289M |
| September 30, 2019 | -2.544M |
| June 30, 2019 | -2.777M |
| March 31, 2019 | -1.457M |
| December 31, 2018 | -2.419M |
| September 30, 2018 | -2.976M |
| Date | Value |
|---|---|
| June 30, 2018 | -2.703M |
| March 31, 2018 | -2.542M |
| December 31, 2017 | -0.76M |
| September 30, 2017 | -1.88M |
| June 30, 2017 | -2.308M |
| March 31, 2017 | -2.993M |
| December 31, 2016 | -2.102M |
| September 30, 2016 | -2.986M |
| June 30, 2016 | -1.249M |
| March 31, 2016 | -1.043M |
| December 31, 2015 | -3.314M |
| September 30, 2015 | -3.502M |
| June 30, 2015 | -4.98M |
| March 31, 2015 | -4.257M |
| December 31, 2014 | -4.033M |
| September 30, 2014 | -3.725M |
| June 30, 2014 | -3.311M |
| March 31, 2014 | -2.895M |
| December 31, 2013 | -3.255M |
| September 30, 2013 | -4.017M |
| June 30, 2013 | -3.778M |
| March 31, 2013 | -5.851M |
| December 31, 2012 | -4.955M |
| September 30, 2012 | -2.703M |
| June 30, 2012 | -3.813M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.758M
Minimum
Dec 2023
-1.275M
Maximum
Jun 2020
-3.746M
Average
-3.078M
Median
Cash from Operations (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 3.366M |
| Protalix BioTherapeutics Inc | 4.105M |
| Electromed Inc | 2.309M |
| Xtant Medical Holdings Inc | -1.718M |
| Armata Pharmaceuticals Inc | -8.863M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.334M |
| Cash from Financing (Quarterly) | 0.137M |
| Free Cash Flow | -21.33M |
| Free Cash Flow Per Share (Quarterly) | -0.0567 |
| Free Cash Flow to Equity (Quarterly) | -3.363M |
| Free Cash Flow Yield | -194.4% |